GP | MIN | FGM | FGA | FG% | 3PM | 3PA | 3P% | FTM | FTA | FT% | OREB | DREB | REB | AST | TOV | STL | BLK | PF | DD2 | TD3 | PTS | +/- |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
76 | 2610 | 586 | 1211 | 0.484% | 92 | 313 | 0.294% | 106 | 129 | 0.822% | 210 | 591 | 801 | 254 | 120 | 50 | 60 | 190 | 0 | 0 | 1370 | 0 |
GP | MIN | FGM | FGA | FG% | 3PM | 3PA | 3P% | FTM | FTA | FT% | OREB | DREB | REB | AST | TOV | STL | BLK | PF | DD2 | TD3 | PTS | +/- |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
64 | 2016 | 470 | 950 | 0.49% | 55 | 161 | 0.29% | 103 | 134 | 0.76% | 161 | 513 | 674 | 183 | 111 | 54 | 57 | 157 | 0 | 0 | 1098 | 0 |
SEASON | TEAM | GP | MIN | FGM | FGA | FG% | 3PM | 3PA | 3P% | FTM | FTA | FT% | OREB | DREB | REB | AST | TOV | STL | BLK | PF | DD2 | TD3 | PTS | +/- |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023 | CHI | 76 | 2610 | 586 | 1211 | 0.484% | 92 | 313 | 0.294% | 106 | 129 | 0.822% | 210 | 591 | 801 | 254 | 120 | 50 | 60 | 190 | 0 | 0 | 1370 | 0 |
2022 | CHI | 82 | 2746 | 597 | 1148 | 0.52% | 121 | 347 | 0.349% | 132 | 158 | 0.835% | 159 | 744 | 903 | 265 | 139 | 60 | 57 | 179 | 0 | 0 | 1447 | 0 |
2021 | CHI | 73 | 2418 | 546 | 1154 | 0.473% | 104 | 331 | 0.314% | 92 | 121 | 0.76% | 142 | 662 | 804 | 236 | 136 | 70 | 71 | 181 | 0 | 0 | 1288 | 0 |
2020 | ORL | 44 | 1500 | 436 | 908 | 0.48% | 117 | 288 | 0.406% | 91 | 110 | 0.827% | 87 | 430 | 517 | 167 | 83 | 42 | 28 | 79 | 0 | 0 | 1080 | 0 |
2020 | CHI | 26 | 848 | 230 | 488 | 0.471% | 59 | 152 | 0.388% | 40 | 46 | 0.87% | 59 | 241 | 300 | 102 | 43 | 23 | 20 | 58 | 0 | 0 | 559 | 0 |
2019 | ORL | 62 | 1998 | 493 | 1033 | 0.477% | 98 | 289 | 0.339% | 131 | 167 | 0.784% | 140 | 533 | 673 | 222 | 88 | 54 | 47 | 135 | 0 | 0 | 1215 | 0 |
2018 | ORL | 80 | 2510 | 701 | 1354 | 0.518% | 84 | 231 | 0.364% | 179 | 227 | 0.789% | 224 | 736 | 960 | 307 | 159 | 81 | 89 | 157 | 0 | 0 | 1665 | 0 |
2017 | ORL | 57 | 1683 | 399 | 840 | 0.475% | 64 | 204 | 0.314% | 77 | 94 | 0.819% | 101 | 422 | 523 | 191 | 109 | 56 | 62 | 144 | 0 | 0 | 939 | 0 |
2016 | ORL | 75 | 2163 | 483 | 1031 | 0.468% | 23 | 75 | 0.307% | 107 | 160 | 0.669% | 176 | 603 | 779 | 208 | 117 | 76 | 74 | 180 | 0 | 0 | 1096 | 0 |
2015 | ORL | 65 | 2037 | 533 | 1046 | 0.51% | 2 | 9 | 0.222% | 113 | 150 | 0.753% | 174 | 402 | 576 | 179 | 123 | 53 | 70 | 173 | 0 | 0 | 1181 | 0 |
2014 | ORL | 74 | 2529 | 631 | 1206 | 0.523% | 2 | 6 | 0.333% | 164 | 218 | 0.752% | 238 | 572 | 810 | 147 | 148 | 54 | 54 | 220 | 0 | 0 | 1428 | 0 |
2013 | ORL | 57 | 1812 | 353 | 696 | 0.507% | 0 | 0 | 0% | 105 | 137 | 0.766% | 185 | 441 | 626 | 104 | 112 | 60 | 47 | 169 | 0 | 0 | 811 | 0 |
2012 | ORL | 77 | 2559 | 461 | 889 | 0.519% | 0 | 3 | 0% | 86 | 126 | 0.683% | 273 | 644 | 917 | 143 | 141 | 61 | 79 | 218 | 0 | 0 | 1008 | 0 |
2011 | PHI | 51 | 812 | 131 | 291 | 0.45% | 3 | 8 | 0.375% | 18 | 34 | 0.529% | 88 | 158 | 246 | 31 | 33 | 20 | 34 | 111 | 0 | 0 | 283 | 0 |